BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION AND THE LOCALIZATION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Manzella, L. [1 ]
Massimino, M. [1 ]
Fallica, M. [1 ]
Consoli, M. L. [1 ]
Aloisi, A. [1 ]
Messina, A. [1 ]
Vigneri, P. [1 ]
机构：
[1] Univ Catania, Dept Biomed Sci, Sect Gen Pathol, Catania, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C052
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [31] Interferon regulatory factor 5 (IRF-5) modulates the cross talk between innate and adaptive immune responses to pathogen infection
    Fang, Chee-Mun
    Lee, Hubert
    Stager, Simona
    Pitha, Paula M.
    CYTOKINE, 2010, 52 (1-2) : 61 - 61
  • [32] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
    Druker, BJ
    Sawyers, CL
    Kantarjian, H
    Resta, DJ
    Reese, SF
    Ford, JM
    Capdeville, R
    Talpaz, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1038 - 1042
  • [33] BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells
    Moriyama, Kenta
    Hori, Toshiyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) : 591 - 598
  • [34] BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells
    Kenta Moriyama
    Toshiyuki Hori
    International Journal of Hematology, 2019, 110 : 591 - 598
  • [35] The transcription factor IRF8 overrides BCR-ABL to rescue dendritic cell development in chronic myeloid leukemia
    Watanabe, Tomoya
    Hotta, Chie
    Koizumi, Shin-ichi
    Miyashita, Kazuho
    Nakabayashi, Jun
    Kurotaki, Daisuke
    Sato, Go R.
    Yamamoto, Michio
    Nishiyama, Akira
    Aihara, Michiko
    Ishigatsubo, Yoshiaki
    Tamura, Tomohiko
    CYTOKINE, 2013, 63 (03) : 308 - 308
  • [36] Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
    Vigneri, P
    Wang, JYJ
    NATURE MEDICINE, 2001, 7 (02) : 228 - 234
  • [37] Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors
    Cortes, Jorge
    Jabbour, Elias
    Kantarjian, Hagop
    Yin, C. Cameron
    Shan, Jianqin
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Giles, Francis
    Breeden, Megan
    Reeves, Nubia
    Wierda, William G.
    Jones, Dan
    BLOOD, 2007, 110 (12) : 4005 - 4011
  • [38] Induced Pluripotent Stem Cells (iPSC) From Chronic Myeloid Leukemia: Study of BCR-ABL Addiction and Effect of Tyrosine Kinase Inhibitors
    Bedel, Aurelie, Sr.
    Moreau-Gaudry, Francois
    Pasquet, Jean-Max, Sr.
    Taillepierre, Miguel
    Lippert, Eric
    Lagarde, Valerie
    de Verneuil, Hubert
    Richard, Emmanuel
    Mahon, Francois-Xavier
    BLOOD, 2011, 118 (21) : 1602 - 1603
  • [39] ANALYSIS OF THE REACTIVATION OF HEPATITIS B VIRUS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT WITH INHIBITORS OF THE TYROSINE KINASE BCR-ABL
    Sanz Ruperez, A.
    Ruiz Gomez, F.
    Garcia Gutierrez, V
    Herrera Puente, P.
    Calbacho Robles, M.
    Velazquez Kennedy, K.
    Geijo Roman, Martinez C.
    Lopez Jimenez, J.
    HAEMATOLOGICA, 2017, 102 : 279 - 279
  • [40] Resistance Profiling of BCR-ABL Compound Mutations Linked to Tyrosine Kinase Inhibitor Therapy Failure in Chronic Myeloid Leukemia
    Eide, Christopher A.
    Zabriskie, Matthew S.
    Adrian, Lauren T.
    Lange, Thoralf
    Deininger, Michael W.
    Druker, Brian J.
    O'Hare, Thomas
    BLOOD, 2011, 118 (21) : 616 - 616
12345